Protein tyrosine phosphatase receptor type N2 (PTPRN2)

Protein tyrosine phosphatase receptor type N2 (PTPRN2) is a single-pass transmembrane receptor predominantly expressed in neuroendocrine tissues, including pancreatic islets and the brain. Despite its name, it does not display classical protein tyrosine phosphatase activity; instead, it dephosphorylates phosphatidylinositol lipids and regulates vesicle-mediated secretory processes. PTPRN2 plays critical roles in insulin vesicle accumulation and secretion in pancreatic beta cells, maintenance of neurotransmitter vesicle stores in the brain, and acts as a major autoantigen in type 1 diabetes mellitus. It contributes to metabolic regulation, reproductive hormone balance (especially in females), and has been implicated in various cancers, notably through effects on actin dynamics and cellular migration. Variations in its expression and methylation status are associated with obesity, cancer metastasis, and metabolic disease. There are currently no approved therapeutics directly targeting PTPRN2, but its role as a disease autoantigen and pathway regulator makes it a focus of biomedical research.

Other names

PhogrinIslet cell autoantigen-related protein (ICAAR)IA-2 betaIA-2βPTP-NP

For autoimmunity: Induces an autoimmune response in type 1 diabetes via presentation as an islet autoantigen. For cancer/metastasis or obesity: Altered function or expression affects vesicle trafficking, actin dynamics (via PI phosphates), and potentially signal transduction, thereby contributing to disease phenotypes.